Investments, Funding & Disinvestment

This partnership will fund the construction of a nine-bed NICU and an eight-bed PICU, along with consultation rooms, a pharmacy, and other essential areas.

Caldera raised USD75 million in a Series A financing round led by Atlas Venture, LAV, and venBio, followed by an additional USD37.5 million in a Series A-1 round led by Omega Funds.

The laboratory serves as the country’s primary reference centre for sophisticated testing, disease investigation, genetic analysis, and quality control across all health facilities.

This new 35,000 square foot, purpose-built site represents Novartis’s fourth dedicated RLT facility.

The government has fully funded the first phase of the vaccine manufacturing facility, which has already reached completion.

The program will also work to increase access to chemotherapy and provide essential emotional support services for patients navigating their cancer journey.

This acquisition expands Fullerton Health’s network of high-quality specialist care throughout Southeast Asia.

Environmental sustainability stands as a cornerstone of the 2024 report, with the company achieving a 58% reduction in diesel consumption and a 64% decrease in refrigerant gas usage.

The continued partnership aims to strengthen research focused on developing effective therapeutic options for mpox, a viral disease that currently lacks a dedicated antiviral treatment.

The sale came about following an unsolicited offer from BGH Capital, which focuses on investments in Australia and New Zealand.